Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Clozapine MeSH Descriptor Data 2025


MeSH Heading
Clozapine
Tree Number(s)
D03.633.300.240.220
Unique ID
D003024
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D003024
Scope Note
A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.
Entry Term(s)
Clozaril
Leponex
Pharm Action
Serotonin Antagonists
Antipsychotic Agents
GABA Antagonists
Registry Numbers
J60AR2IKIC
0
Related Numbers
5786-21-0
CAS Type 1 Name
5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-
Previous Indexing
Dibenzazepines (1971-1974)
Piperazines (1971-1974)
Public MeSH Note
91; was see under DIBENZAZEPINES 1975-90
History Note
91(75); was see under DIBENZAZEPINES 1975-90
Date Established
1991/01/01
Date of Entry
1974/11/19
Revision Date
2016/05/28
Clozapine Preferred
Leponex Narrower
Clozaril Narrower
page delivered in 0.141s